✦ LIBER ✦

CA125 regression in ovarian cancer patients treated with intravenous versus intraperitoneal platinum-based chemotherapy: A gynecologic oncology group study

✍ Scribed by Ginger J. Gardner; Raymond E. Baser; Mark F. Brady; Robert E. Bristow; Maurie Markman; David Spriggs; Howard T. Thaler

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CA125 decline in ovarian cancer patients

✍ Debra L. Richardson; Leigh G. Seamon; Matthew J. Carlson; David M. O'Malley; Jef 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 172 KB

Nadir CA125 and second look surgery in p

✍ S. Richard; A. Miller; M. Markman; D. Armstrong; J. Walker; T. Krivak 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 128 KB

A Gynecologic Oncology Group Study of se

✍ Thomas C. Krivak; Chunqiao Tian; G. Scott Rose; Deborah K. Armstrong; G. Larry M 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 318 KB

Prognostic factors for stage III epithel

✍ L. Landrum; J. Java; C. Mathews; G. Lanneau; L. Copeland; D. Armstrong; J. Walke 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Intraperitoneal catheter outcomes in a p

✍ Joan L. Walker; Deborah K. Armstrong; Helen Q. Huang; Jeffrey Fowler; Kenneth We 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Re: Intraperitoneal catheter outcomes in

✍ E. Petru; Ch. Benedicic; A. Huell 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 98 KB